Thomson Reuters

Home / Products & Services / Pharma & Life Sciences

Pharma & Life Sciences

From discovery to development, launch, and beyond: we can help your pipeline flourish and your business grow.

Expand your portfolio and make the best decisions across the life science research cycle. We understand reliable information is critical to your success. We also understand the value of information in context. Manually curated scientific intelligence. Competitive intelligence from expert analysts. Regulatory guidance from global compliance professionals. Unparalleled API intelligence. Delivered when you want it, how you want it.

Research and Development

  • Drug Development

    Get your drug ready for market faster. Enrich your drug R&D with expert insight and multi-disciplined data.

  • Life Science Research

    Optimize your life science research investment with manually-curated scientific data

  • Chemistry Research

    Enrich your pre-clinical research. Expertly curated chemical content from one chemist to another.

  • Clinical Trial Development

    Efficiently get your drug through the clinical phases. Global intelligence for effective trial strategies.

  • Pharmaceutical Research

    Fully capitalize on your innovation. Manually-curated pharmaceutical intelligence for maximum ROI.

  • Systems Biology

    Expand your R&D possibilities. Manually curated systems biology intelligence and pathway analysis.

Business Development

Compliance

  • Regulatory Affairs

    Get to market faster. Ensure your approval process runs smoothly with global Pharma regulatory intelligence.

  • Industry Codes and Standards

    Instantly access one of the largest collections of industry codes and standards. Anytime, anywhere.

Professional Services

  • Pharma Consulting Services

    Scientific and Pharma experts for custom pharmaceutical projects across the life science research cycle.

Key Offerings

Thomson Reuters is the world's leading source of intelligent information for businesses and professionals.

Related Content

Press releases

Back to Top